Northern Light

Most enterprise AI strategies start with the wrong question: build vs. buy.

But model choice isn’t what determines success.

What actually matters is whether your organization has the governed, scalable foundation required to make AI outputs trusted, usable, and decision-ready. Without it, even the most advanced models stall before delivering real value.

If AI is a priority this year, this is the layer most teams are missing.

👉 Read the full blog: https://www.northernlight.com/blog/build-vs-buy-is-the-wrong-question-what-enterprise-ai-actually-requires?utm_source=FB&utm_medium=content&utm_campaign=build+vs+buy

The most important signals in pharma often appear years before products reach the market.

They show up in scientific abstracts, patent filings, and early research—not earnings calls.

Our latest blog explores why life sciences intelligence and early signal detection are becoming essential for pharma competitive intelligence and R&D foresight.

👉 Read the blog: https://www.northernlight.com/blog/what-is-life-sciences-intelligence--and-why-early-signals-matter-more-than-ever?utm_source=meta&utm_medium=social&utm_campaign=march+post